Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound

L Pes, SD Koester, JP Magnusson, S Chercheja… - Journal of Controlled …, 2019 - Elsevier
Auristatins are a class of highly cytotoxic tubulin-disrupting peptides, which have shown
limited therapeutic effect as free agents in clinical trials. In our continuing effort to develop …
被引用次数：26 相关文章

[引用][C] Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound

L Pes, SD Koester, JP Magnusson… - Journal of Controlled …, 2019 - hal.science
Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo
compared to the parent compound - Archive ouverte HAL Accéder directement au contenu …

Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound

L Pes, SD Koester, JP Magnusson… - … : official journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Auristatins are a class of highly cytotoxic tubulin-disrupting peptides, which have shown
limited therapeutic effect as free agents in clinical trials. In our continuing effort to develop …

Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound.

L Pes, SD Koester, JP Magnusson… - Journal of Controlled …, 2019 - europepmc.org
Auristatins are a class of highly cytotoxic tubulin-disrupting peptides, which have shown
limited therapeutic effect as free agents in clinical trials. In our continuing effort to develop …

[引用][C] Novel auristatin E-based albumin-binding prodrugs with superior anticancer efficacy in vivo compared to the parent compound

L Pes, SD Koester, JP Magnusson, S Chercheja… - 2019